Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Raymond James Financial Services Advisors Inc.

Raymond James Financial Services Advisors Inc. cut its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 9.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,385 shares of the company’s stock after selling 672 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in Henry Schein were worth $483,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Morgan Stanley grew its holdings in shares of Henry Schein by 143.4% during the fourth quarter. Morgan Stanley now owns 2,337,890 shares of the company’s stock worth $186,727,000 after purchasing an additional 1,377,207 shares during the last quarter. Norges Bank purchased a new position in shares of Henry Schein during the fourth quarter worth about $109,932,000. Lazard Asset Management LLC grew its holdings in shares of Henry Schein by 1,303.3% during the third quarter. Lazard Asset Management LLC now owns 1,247,334 shares of the company’s stock worth $92,614,000 after purchasing an additional 1,158,451 shares during the last quarter. Boston Partners grew its holdings in shares of Henry Schein by 4,975.9% during the third quarter. Boston Partners now owns 1,080,598 shares of the company’s stock worth $80,229,000 after purchasing an additional 1,059,309 shares during the last quarter. Finally, Point72 Asset Management L.P. purchased a new position in shares of Henry Schein during the second quarter worth about $36,288,000. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now directly owns 73,108 shares in the company, valued at approximately $5,430,462.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the sale, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the sale, the insider now directly owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on HSIC. Piper Sandler raised their price objective on Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a report on Monday, February 26th. Barrington Research raised their price target on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a report on Wednesday, February 28th. Evercore ISI raised their price target on Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a report on Wednesday, February 28th. Leerink Partnrs reissued a “market perform” rating on shares of Henry Schein in a report on Monday, February 26th. Finally, JPMorgan Chase & Co. raised their price target on Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a report on Wednesday, March 6th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $81.09.

Henry Schein Price Performance

Shares of NASDAQ:HSIC opened at $70.86 on Friday. The company has a quick ratio of 1.00, a current ratio of 1.67 and a debt-to-equity ratio of 0.45. The company has a market cap of $9.10 billion, a P/E ratio of 22.50, a PEG ratio of 1.74 and a beta of 0.87. Henry Schein, Inc. has a 52 week low of $60.01 and a 52 week high of $85.39. The company has a 50-day moving average price of $74.37 and a 200 day moving average price of $72.47.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The company had revenue of $3.02 billion for the quarter, compared to analyst estimates of $3 billion. During the same quarter in the previous year, the business posted $1.21 earnings per share. Henry Schein’s revenue was down 10.5% on a year-over-year basis. Research analysts predict that Henry Schein, Inc. will post 5.07 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.